World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
50
Citations
7998
World Ranking
17726
National Ranking
1281

Eishi Ashihara publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Eishi Ashihara sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 304 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Eishi Ashihara D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Eishi Ashihara sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 50 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Eishi Ashihara is affiliated with Kyoto Pharmaceutical University in Japan. Their academic output primarily spans the fields of Biochemistry, Genetics and Molecular Biology with 32 publications, and Medicine with 20 publications. Within these broad areas, Ashihara's subfields of study include Molecular Biology, Immunology, Oncology, Hematology, and Cancer Research.

The scientist's research topics include:

  • Ubiquitin and proteasome pathways
  • Protein degradation and inhibitors
  • Multiple myeloma research and treatments
  • Immune cell function and interaction
  • T-cell and B-cell immunology
  • Extracellular vesicles in disease
  • RNA interference and gene delivery

Ashihara has several recent papers illustrating their research interests. These include:

  • "Plasma membrane anchored nanosensor for quantifying endogenous production of H2O2 in living cells" (2021), published in Biosensors and Bioelectronics
  • "Cytotoxic activities of sesquiterpenoids from the aerial parts of Petasites japonicus against cancer stem cells" (2020), published in Journal of Natural Medicines
  • "Human Vγ9Vδ2 T cells exert anti-tumor activity independently of PD-L1 expression in tumor cells" (2021), published in Biochemical and Biophysical Research Communications
  • "Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application" (2021), published in International Journal of Molecular Sciences
  • "Mouse Bone Marrow-derived Microglia-like Cells Secrete Transforming Growth Factor-β1 and Promote Microglial Aβ Phagocytosis and Reduction of Brain Aβ" (2020), published in Neuroscience

Frequent co-authors of Ashihara include:

  • Yuki Toda
  • Shigekuni Hosogi
  • Kazuyuki Takata
  • Mako Tomogane
  • Teruki Shimizu

Among frequent publication venues, Ashihara has contributed notably to:

  • Biochemical and Biophysical Research Communications (6 publications)
  • Journal of Natural Medicines (2 publications)
  • Anticancer Research (2 publications)
  • Biosensors and Bioelectronics (1 publication)
  • International Journal of Molecular Sciences (1 publication)

Best Publications

  • Induced-Pluripotent-Stem-Cell-Derived Primitive Macrophages Provide a Platform for Modeling Tissue-Resident Macrophage Differentiation and Function.

    Kazuyuki Takata;Kazuyuki Takata;Tatsuya Kozaki;Christopher Zhe Wei Lee;Morgane Sonia Thion

  • NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia.

    Shinya Kimura;Haruna Naito;Hidekazu Segawa;Junya Kuroda

  • Targeting the Wnt/β-catenin signaling pathway in human cancers.

    Hisayuki Yao;Eishi Ashihara;Eishi Ashihara;Taira Maekawa

  • Myeloid-Derived Suppressor Cells Play Crucial Roles in the Regulation of Mouse Collagen-Induced Arthritis

    Wataru Fujii;Eishi Ashihara;Eishi Ashihara;Hideyo Hirai;Hidetake Nagahara

  • Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration.

    Kento Tateishi;Eishi Ashihara;Naofumi Takehara;Tetsuya Nomura;Tetsuya Nomura

  • INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity

    Asumi Yokota;Shinya Kimura;Satohiro Masuda;Eishi Ashihara

  • Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease.

    M Okamoto;A Okano;S Akamatsu;E Ashihara

  • Intracoronary Transplantation of Non-Expanded Peripheral Blood-Derived Mononuclear Cells Promotes Improvement of Cardiac Function in Patients With Acute Myocardial Infarction

    Tetsuya Tatsumi;Eishi Ashihara;Toshihide Yasui;Shinsaku Matsunaga

  • Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways

    T Kobayashi;J Kuroda;E Ashihara;S Oomizu

  • Targeting the canonical Wnt/β-catenin pathway in hematological malignancies.

    Eishi Ashihara;Tetsuya Takada;Taira Maekawa

  • Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia

    Mio Yamamoto-Sugitani;Junya Kuroda;Eishi Ashihara;Hisao Nagoshi

  • Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3β signaling

    Kento Tateishi;Eishi Ashihara;Shoken Honsho;Shoken Honsho;Naofumi Takehara

  • Zoledronic Acid -a Multiplicity of Anti-Cancer Action

    Takeshi Yuasa;Shinya Kimura;Eishi Ashihara;Tomonori Habuchi

  • Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines.

    Yasuyuki Deguchi;Shinya Kimura;Eishi Ashihara;Tomoko Niwa

  • Non–T-cell–depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism

    Chihiro Shimazaki;Naoya Ochiai;Ryo Uchida;Akira Okano

  • Synergistic Effect of FLT-3 Ligand on the Granulocyte Colony-Stimulating Factor–Induced Mobilization of Hematopoietic Stem Cells and Progenitor Cells Into Blood in Mice

    Yoshikazu Sudo;Chihiro Shimazaki;Eishi Ashihara;Takehisa Kikuta

  • B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study.

    Chihiro Shimazaki;Tohru Inaba;Kazuho Shimura;Akio Okamoto

  • Significance of C4d staining in ABO-identical/compatible liver transplantation

    Hiromi Sakashita;Hironori Haga;Eishi Ashihara;Mei Chin Wen

  • Future prospect of RNA interference for cancer therapies.

    Eishi Ashihara;Eri Kawata;Taira Maekawa

  • Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia

    J Kuroda;S Kimura;A Strasser;M Andreeff

Frequent Co-Authors

Masafumi Taniwaki
Masafumi Taniwaki Kyoto Prefectural University of Medicine
Jiro Imanishi
Jiro Imanishi Kyoto Prefectural University of Medicine
Daniel G. Tenen
Daniel G. Tenen National University of Singapore
Shun Shimohama
Shun Shimohama Sapporo Medical University
Michael Andreeff
Michael Andreeff The University of Texas MD Anderson Cancer Center
Hiroto Egawa
Hiroto Egawa Kyoto University
Masatsugu Horiuchi
Masatsugu Horiuchi Ehime University
Satohiro Masuda
Satohiro Masuda Himeji Dokkyo University
Kazuma Ohyashiki
Kazuma Ohyashiki Tokyo Medical University
Akira Yamauchi
Akira Yamauchi Kawasaki Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Biology and Biochemistry have a variety of online programs and career pathways to consider. The expanding field of health and life sciences offers flexible options to grow your knowledge, specialize, or transition into new roles.

For those drawn to fitness, health, and rehabilitation, an exercise science degree online provides training in physiology and human performance. Similarly, if you want a strong foundation in movement science and wellness, an online bachelor's in kinesiology offers coursework suited for aspiring coaches, therapists, or wellness consultants.

For advanced healthcare professionals, there are fast-track options to specialize further. The shortest post master's pmhnp online programs prepare nurses for mental health leadership. Meanwhile, those interested in family care might explore the shortest post master's fnp program to quickly become a certified family nurse practitioner.

These diverse online options make it easier to align your studies in Biology and Biochemistry with career goals in healthcare, exercise, or advanced nursing practice—no matter where you live.

Best Scientists Citing Eishi Ashihara

Trending Scientists

Recently Published Articles